Lv617
1907 积分 2023-12-03 加入
Antibody-drug conjugate design and mechanisms of action for cancer treatment: state of the art and beyond
1小时前
待确认
A native SEC-MS workflow and validation for analyzing drug-to-antibody ratio and drug load distribution in cysteine-linked antibody-drug conjugates
5小时前
待确认
Process Development of Site-Specific Antibody–Drug Conjugates
4天前
已完结
Characterization of Disulfide Bonds in Cyclic Peptides Using Electron Transfer–Ultraviolet Photodissociation Mass Spectrometry
4天前
已完结
Developing analytical ion exchange chromatography methods for antibody drug conjugates containing the hydrolysis-prone succinimide-thioether conjugation chemistry
7天前
已完结
Impurity qualification requirements for drug-linkers related impurities used to generate antibody-drug conjugates
8天前
已完结
Rapid and Efficient Antibody–Drug Conjugate Design Using Mechanistic Bottom-Up Modeling from In Vitro to Human
9天前
已完结
Development of a High-Throughput Size-Exclusion Chromatography–Mass Spectrometry Workflow for Real-Time Monitoring of Bioconjugation of Cysteine-Based Antibody–Drug Conjugates
9天前
已完结
From R&D to Clinical Supplies
21天前
已完结
A Case Study on the Impact of Thermal Hydrolysis and Lactone Ring Opening of Linker-Payload on Drug-to-Antibody Ratio Determination in a Topoisomerase I Inhibitor-Based ADC
21天前
已完结
皖公网安备34019202002308
